My Profile
Matthew Goldstein
Raising intellectual capital on Wall Street
See all posts
Thu 3 Dec 2009 | 12:44 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals, Inc. (ACUR.O) (Consolidated Issue listed on NASDAQ Capital Market)
sector:
Healthcare
.
industry:
Pharmaceuticals - Generic & Specialty
ยท
View
ACUR
on other exchanges
As of 12:05pm EST
4.72
USD
Price Change
+0.03
Percent Change
+0.64%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Total Annual Compensation
Long-Term Incentive Plans
All Other
Fiscal Year Total
As Of 30 Dec 2008
Boehm, Garth
--
--
--
--
Brzeczko, Albert
--
--
--
--
Clemens, Peter
307,500
--
276,000
583,500
Emigh, James
280,000
--
7,000
331,000
Jones, Robert
342,423
--
544,000
1,059,423
Markham, Richard
--
--
--
--
Reddick, Andrew
693,500
--
691,000
1,384,500
Ross, George
--
--
--
--
Seiser, Robert
216,000
--
221,000
437,000
Skelly, William
--
--
--
--
Sumner, William
--
--
--
--
Thangaraj, Immanuel
--
--
--
--
Wesson, Bruce
--
--
--
--
Find out more about ACUR.O
Insider Trading